Characterization of the oral fungal microbiota in smokers and non-smokers by Monteiro-da-Silva, F et al.
Short communication
Characterization of the oral fungal
microbiota in smokers and non-
smokers
Monteiro-da-Silva F, Sampaio-Maia B, Pereira ML, Araujo R. Characterization of the
oral fungalmicrobiota in smokers and non-smokers.
Eur JOral Sci 2013; 121: 132–135.© 2013Eur JOral Sci
This study aimed to assess the eﬀect of smoking on the biodiversity of the oral fun-
gal microbiota of healthy young subjects, using an improved culture method that
assesses both total and pathogenic viable fungi. Forty individuals (20 smokers and
20 non-smokers) were selected. All individuals presented fungal growth (100% for
molds and 92.5% for yeasts), a prevalence higher than previously reported. The
most commonly occurring molds were Penicillium sp., Aspergillus sp., and Cladospo-
rium sp. Smokers presented signiﬁcantly higher levels of yeasts and pathogenic
molds than did non-smokers. No diﬀerences in fungal prevalence and diversity were
observed in smokers and non-smokers following a 30-wk observation period. In
conclusion, tobacco smoking may alter the oral mycobiota and facilitate coloniza-
tion of the oral cavity with yeasts and pathogenic molds. The eﬀect of chronic fun-
gal colonization on the oral health of tobacco smokers cannot be neglected.
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The oral microbiota constitutes one of the most com-
plex communities in the human body and is composed
of up to 19,000 phylotypes (1–3). However, this mi-
crobiome is continuously exposed to a variety of hos-
tile factors that can aﬀect the microbial balance of the
oral mucosa. One of the most relevant factors in this
regard is smoking habit, which is quite common in the
global world society and is associated with relevant
oral diseases, such as periodontitis and oral cancer.
The higher prevalence and greater severity of oral dis-
ease in smokers might be explained by the altered host
immune response as disturbances in immunoglobulin
and cytokine levels, altered lymphocyte counts, and
impairment of oral neutrophil function demonstrated
in smokers (4–6). Numerous studies have reported that
in comparison with non-smokers, smokers present
enhanced levels of certain bacterial species in supragin-
gival and subgingival plaque, namely members of the
orange and red bacterial complexes, including Bactero-
ides forsythus, Eubacterium nodatum, Fusobacterium nu-
cleatum ssp. vincentii, Peptostreptococcus micros,
Prevotella intermedia, Prevotella nigrescens, Porphyro-
monas gingivalis, and Treponema denticola (4, 7). In
contrast, other studies have found no signiﬁcant diﬀer-
ences in the composition of the subgingival periodonto-
pathogenic microbiota of smokers with periodontal
disease (5, 8).
With respect to fungi, tobacco smokers have a higher
rate of oral Candida carriage than do non-smokers (9,
10). A number of studies over the past two decades
have found evidence that smoking, either alone or in
combination with other factors (such as denture wear-
ing and diabetes), appears to be an important predis-
posing factor for oral candidosis (11). Furthermore,
clinicians suggest that some yeast infections invariably
disappear following smoking cessation, without addi-
tional therapy (12).
GHANNOUM et al. (1) analyzed the fungal component
of the oral microbiota by pyrosequencing and described
several genera previously neglected in the oral cavity.
The purpose of the present investigation was to
assess the eﬀect of smoking on the biodiversity of oral
fungal microbiota – yeasts and molds – of healthy sub-
jects, using improved culture methods followed by bio-
chemical multitesting and molecular methods for
identiﬁcation.
Material and methods
Forty healthy students from the ﬁfth year of the Masters
Degree of the Faculty of Dental Medicine of Porto Uni-
versity were invited to participate voluntarily. The Ethics
Committee of same faculty approved the consent form
and the research protocol. The medical and dental histo-
ries of each subject, as well as information on oral hygiene
habits, alcohol consumption habits, and contraceptive
drug use, were obtained by interview. Oral clinical exami-
nation included assessment of probing depth, gingival
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recession, and bleeding on probing at six sites per tooth
(mesiobuccal, midbuccal, distobuccal, mesiolingual, mid-
lingual, and distolingual) for all teeth. Caries prevalence
was assessed using the decayed, missing or ﬁlled surfaces
(DMFS) index, and oral hygiene was assessed using the
O’Leary plaque control record (13, 14).
Study participants rinsed their mouth with 10 ml of ster-
ile water for 15 s, and the samples were taken up in 250 ml
of Sabouraud glucose agar supplemented with chloramphe-
nicol. The culture medium was divided among 10 Petri
dishes and incubated at 25°C or 37°C for 7 d, to monitor
the growth of total and pathogenic fungi (15). The number
of fungal colonies were registered as colony-forming units
per ml (CFU/ml) and the growing fungi were identiﬁed
based on macroscopic and microscopic morphology (16).
API ID 32C (BioMerieux, Hazelwood, MO, USA) was used
for yeast identiﬁcation. All fungi showing unreliable tradi-
tional identiﬁcation were recognized by sequencing 18S and
internal transcribed spacer (ITS) regions, employing a previ-
ously suggested set of primers (17, 18).
A value of P < 0.05 was considered statistically signiﬁ-
cant. The categorical variables were described using rela-
tive frequencies (%), whereas continuous variables were
described using mean  SD. The chi-square test of inde-
pendence was used to analyze the categorical variables and
the Mann–Whitney U-test was used for continuous vari-
ables. The statistical analyses were performed using SPSS
v.17.0 (IBM SPSS Statistics, Armonk, NY, USA).
Results and discussion
The ﬁnal sample included 26 women (65%) and 14
men (35%), aged between 22 and 34 yr (mean
age  SD = 24.0  2.8 yr). The mean oral hygiene
index was 45.1  12.1 and the DMFS index was
7.5  7.3.
The non-smoker group comprised 20% men (mean
age  SD = 23.2  1.8 yr), whereas the smoker group
comprised 50% men (mean age  SD = 24.8  3.4 yr).
Smokers had consumed a mean of 8.5  6.0 cigarettes
a day for a period of 4.5  4.1 yr. No diﬀerences were
found between smokers and non-smokers regarding
oral hygiene, DMFS, and periodontal indexes (Table
S1).
All subjects presented colonization of the oral cavity
with fungi. Two sets of samples, incubated at diﬀerent
temperatures, were analyzed: (i) the samples incubated
at 25°C showed a prevalence of 100% for molds and a
prevalence of ~92% for yeasts in both smokers and
non-smokers, and (ii) the samples incubated at 37°C
showed a prevalence of molds of ~42% in smokers and
in non-smokers, whilst the prevalence of yeasts was
55% in smokers and 35% in non-smokers. For general
analysis, samples at 25°C were preferable, given that
higher recovery rates are actually more representative
of the degree of oral fungal colonization in vivo. An
incubation temperature of 37°C was preferable for
growth of a few pathogenic fungi, such as Candida albi-
cans and Aspergillus fumigatus.
Table 1 depicts the comparison of mold and yeast
counts obtained in oral samples positive for fungi from
smokers and non-smokers. Smokers had signiﬁcantly
higher levels of yeasts in samples incubated at 25°C. At
37°C, signiﬁcantly higher levels of molds and total
fungi were found in smokers.
Based on microscopic features and API results, we
were able to identify the following yeasts: Candida spp.
(C. albicans, Candida parapsilosis, and Candida tropical-
is) and Rhodotorula sp. Seven diﬀerent genera of molds
were identiﬁed: Penicillium, Aspergillus, Cladosporium,
Alternaria, Trichoderma, Scedosporium, and Rhizopus;
~70% of molds were not identiﬁed (Table S2). Penicil-
lium sp. molds were those most frequently identiﬁed,
followed by Aspergillus sp. and Cladosporium sp.
Within the genus Aspergillus the most frequent species
was A. fumigatus, which was found in 40% of all sub-
jects. Other species, such as Aspergillus flavus and
Aspergillus glaucus, were also isolated sporadically.
Molecular identiﬁcation revealed few atypical colonies
of Penicillium sp. and Cladosporium sp. (non-sporulat-
ing molds with white branches and septate hyphae).
Details on the quantiﬁcation of each fungal phylotype
in smokers and non-smokers are presented in Table S2
as well as individual information on fungal phylotypes
(Figure S1).
To assess individual and temporal variation of oral
fungi colonization, a follow up of 10 subjects was car-
ried out 6 months after the ﬁrst sampling (data not
shown). The demographic characteristics and smoking
habits of these individuals in the follow-up sample were
similar to those of the initial sample. The analysis
revealed that the participants were colonized with the
same fungal taxa at the two sampling periods, regard-
less of smoking habit. Frequencies of isolation of oral
fungi, as well as the concentration of fungi, were con-
stant over the 6-month observation period. Other vari-
ables, such as oral contraceptive drugs and alcohol
consumption habits, did not inﬂuence the prevalence
and growth of fungi (P > 0.05).
The study aimed to characterize the oral mycobiota
and to assess the eﬀect of tobacco smoking on the
prevalence and concentration of viable fungi in the oral
Table 1
Fungal quantification in smokers and non-smokers (positive
samples for fungi)
Culture
conditions Smokers CFUs Non-smokers CFUs P-value
25°C for 7 d
Yeasts 60.7  97.8* (18) 5.4  36.7* (19) 0.037
Molds 5.4  2.4 (20) 5.6  2.1 (20) 0.507
Total fungi 60.1  92.6* (20) 20.6  35.5* (20) 0.068
37°C for 7 d
Yeasts 98.4  106.4* (11) 28.3  25.6* (7) 0.258
Molds 1.5  1.7 (8) 0.4  0.2 (9) 0.019
Total fungi 73.0  100.1* (15) 14.4  22.6* (14) 0.041
Colony-forming unit (CFU) values are given as mean CFUs/
ml  SD with the number of samples in parentheses. P-values
were calculated using the Mann–Whitney U-test.
*High SD values as a result of the presence of 30% of smok-
ers and 10% of non-smokers with yeasts counts >80 CFU/ml.
P-value in bold represent statistically signiﬁcant diﬀerences.
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cavity of healthy participants showing good indices of
oral health and hygiene. All subjects showed coloniza-
tion of the oral cavity with fungi. However, higher lev-
els of oral colonization with both yeasts and molds
were found in tobacco smokers. The oral fungi identi-
ﬁed in this study included the yeasts Candida sp. and
Rhodotorula sp. and a variety of mold genera. Our
results are consistent with those obtained recently by
GHANNOUM et al. (1). By taking up the oral rinse sam-
ples in liquid Sabouraud agar, it was possible to isolate
and identify a higher number of yeasts and molds than
previously reported using traditional culture methods.
The diversity of yeasts and molds found in the present
study has never been reported previously in healthy
young individuals employing culture methods (19).
We did not ﬁnd any diﬀerences in the prevalence and
concentration of oral fungi among smokers and non-
smokers. However, the yeast counts, particularly Can-
dida sp., seemed somewhat higher in smokers but did
not attain statistical signiﬁcance. Candida sp. are con-
sidered as the most important and prevalent colonizing
fungi of the oral mucosa, being associated with oral
diseases, especially in immune-compromised hosts (1,
20). Our results are consistent with the literature in that
the rate of oral candida carriage was higher in smokers
than in non-smokers (21–23). Some candidal infections
invariably disappear following smoking cessation (12).
Furthermore, smokers may present higher counts
of pathogenic molds (obtained upon culture at 37°C),
suggesting that the growth of these fungi is favored by
smoking. In this respect it is of interest that several
authors reported a high risk of invasive and chronic
pulmonary aspergillosis in tobacco and marijuana
consumers (24–26). Although adverse eﬀects related
to exposure to molds are rarely reported in healthy
individuals, the potential eﬀects of chronic exposure to
relatively high concentrations of mold should not be
disregarded. Most fungal species found in the oral
mucosa, particularly Penicillium sp., are mycotoxin
producers. Mycotoxins are responsible for well-known
toxigenic activities, causing the inhibition of protein
synthesis and immunosuppression (27).
The immune-system deﬁciencies in smokers highlight
the importance of oral fungi colonization, mainly with
respect to opportunistic pathogens such as Candida
spp. and Aspergillus spp. The oral mucosa could func-
tion as portal for systemic fungal infections, particu-
larly in immunocompromised individuals.
It is important to note that the presence of molds in
the oral habitat may be a result of transient coloniza-
tion. However, it is interesting that the colonization
proﬁle of both smokers and non-smokers was main-
tained over a 6-month period.
In conclusion, tobacco smoking may alter the oral
mycobiome, facilitating the colonization of the oral
cavity and favoring certain yeasts and pathogenic
molds. Although the underlying mechanisms are still
unclear, possible alterations in the host immune
response could be of relevance. Our data highlight the
importance of tobacco control because it has been pro-
ven that smoking cessation alone may reverse opportu-
nistic fungal infections in the oral cavity and probably
also in other body sites.
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Supporting Information
Additional Supporting Information may be found in the online
version of this article:
Fig. S1. Overall distribution of diﬀerent mold phylotypes in each
individual.
Table S1. Clinical characterization of smokers and non-smokers.
Table S2. Fungi genera quantiﬁcation and prevalence in oral sam-
ples from smokers and non-smokers at 25°C and 37°C.
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